🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 04351P101
- Market Cap
- Large Cap · $1 Billion
- IPO
- 1/27/2015 · $18.00/share
- ADR Ratio
- 1:1
Business: Ascendis Pharma A/S is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.
Company Contact
- CEO
- Jan Møller Mikkelsen
- CFO
- Scott Smith
- Headquarters
- 530 Lytton Avenue, 2nd Floor, Palo Alto, CA 94301
- Phone
- 650-617-3406
- Fax
- 650-617-3201
- Investor Relations
- Martin Auster · 650-617-3403 · ir@ascendispharma.com